EULAV Asset Management Lowers Stock Holdings in U.S. Physical Therapy, Inc. (NYSE:USPH)

EULAV Asset Management trimmed its holdings in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 25.7% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 19,100 shares of the company's stock after selling 6,600 shares during the period. EULAV Asset Management owned 0.13% of U.S. Physical Therapy worth $1,382,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. CBIZ Investment Advisory Services LLC grew its position in shares of U.S. Physical Therapy by 59.8% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company's stock valued at $29,000 after buying an additional 122 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of U.S. Physical Therapy in the 4th quarter valued at about $39,000. Fifth Third Bancorp grew its position in shares of U.S. Physical Therapy by 34.6% in the 1st quarter. Fifth Third Bancorp now owns 1,030 shares of the company's stock valued at $75,000 after buying an additional 265 shares during the last quarter. Lazard Asset Management LLC bought a new stake in shares of U.S. Physical Therapy in the 4th quarter valued at about $84,000. Finally, Aquatic Capital Management LLC grew its position in shares of U.S. Physical Therapy by 18.0% in the 4th quarter. Aquatic Capital Management LLC now owns 1,298 shares of the company's stock valued at $115,000 after buying an additional 198 shares during the last quarter.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on USPH. Wall Street Zen raised U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research note on Thursday, May 8th. JMP Securities reissued a "market outperform" rating and issued a $113.00 price objective on shares of U.S. Physical Therapy in a research note on Tuesday, April 22nd. JPMorgan Chase & Co. dropped their price objective on U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating on the stock in a research note on Wednesday, March 19th. Finally, Barrington Research reissued an "outperform" rating and issued a $98.00 price objective on shares of U.S. Physical Therapy in a research note on Tuesday, July 1st. Two equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $109.00.

Insider Activity at U.S. Physical Therapy

In other news, Director Nancy Ham sold 400 shares of the company's stock in a transaction that occurred on Thursday, June 12th. The stock was sold at an average price of $78.01, for a total value of $31,204.00. Following the completion of the transaction, the director directly owned 2,594 shares of the company's stock, valued at $202,357.94. This represents a 13.36% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 2.00% of the stock is currently owned by company insiders.

U.S. Physical Therapy Stock Down 0.1%

USPH stock traded down $0.07 during trading on Thursday, reaching $76.41. 224,449 shares of the stock were exchanged, compared to its average volume of 123,532. The firm's 50 day moving average is $76.48 and its 200 day moving average is $79.29. U.S. Physical Therapy, Inc. has a twelve month low of $62.77 and a twelve month high of $101.20. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.32. The firm has a market cap of $1.16 billion, a P/E ratio of 35.05, a price-to-earnings-growth ratio of 3.72 and a beta of 1.44.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.48 earnings per share for the quarter, topping analysts' consensus estimates of $0.46 by $0.02. The business had revenue of $183.79 million for the quarter, compared to the consensus estimate of $176.78 million. U.S. Physical Therapy had a return on equity of 7.89% and a net margin of 4.57%. The firm's revenue for the quarter was up 18.0% on a year-over-year basis. During the same period in the prior year, the business earned $0.51 EPS. As a group, research analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, June 13th. Stockholders of record on Friday, May 23rd were paid a $0.45 dividend. This represents a $1.80 annualized dividend and a dividend yield of 2.36%. The ex-dividend date of this dividend was Friday, May 23rd. U.S. Physical Therapy's dividend payout ratio (DPR) is presently 82.57%.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.